{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:56:51Z","timestamp":1697457411673},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1993,7,1]],"date-time":"1993-07-01T00:00:00Z","timestamp":741484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[1993,7]]},"DOI":"10.1007\/bf00366445","type":"journal-article","created":{"date-parts":[[2004,11,2]],"date-time":"2004-11-02T13:39:18Z","timestamp":1099402758000},"page":"186-194","source":"Crossref","is-referenced-by-count":11,"title":["Double ?-lactam regimen compared to an aminoglycoside\/?-lactam regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients"],"prefix":"10.1007","volume":"1","author":[{"given":"Jai H.","family":"Joshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bary W.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca S.","family":"Finley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Ruxer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Moody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C.","family":"Schimpff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0025-7125(16)32514-7","volume":"55","author":"D Armstrong","year":"1971","unstructured":"Armstrong D, Young LS, Meyer RD, et al (1971) Infectious complications of neoplastic disease. Med Clin North Am 55:729","journal-title":"Med Clin North Am"},{"key":"CR2","first-page":"1083","volume":"36","author":"JF Bender","year":"1979","unstructured":"Bender JF, Fortner CL, Schimpff SC, Grove WR, Hahn DM, Love LJ, Wiernik PH (1979) Comparative auditory toxicity of aminoglycoside antibiotics in leukopenic patients. Am J Hosp Pharm 36:1083?1087","journal-title":"Am J Hosp Pharm"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005792-197605000-00005","volume":"55","author":"H-Y Chang","year":"1976","unstructured":"Chang H-Y, Rodriguez V, Narboni G, et al (1976) Causes of death in adults with acute leukemia. Medicine 55:259?268","journal-title":"Medicine"},{"key":"CR4","first-page":"539","volume":"1","author":"FJ Danhauer","year":"1983","unstructured":"Danhauer FJ, Fortner CL, Schimpff SC, Jongh CA de, Wesley MN, Wiernik PH (1983) Ototoxicity in granulocytopenic cancer patients associated with pharmacokinetically dosed amikacin. Clin Pharm 1:539?543","journal-title":"Clin Pharm"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/infdis\/137.1.14","volume":"137","author":"EORTC International Antimicrobial Therapy Project Group","year":"1978","unstructured":"EORTC International Antimicrobial Therapy Project Group (1978) Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. J Infect Dis 137:14?29","journal-title":"J Infect Dis"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJM198712313172703","volume":"317","author":"EORTC International Antimicrobial Therapy Cooperative Group","year":"1987","unstructured":"EORTC International Antimicrobial Therapy Cooperative Group (1987) Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. N Engl J Med 317:1692?1698","journal-title":"N Engl J Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/AAC.27.4.605","volume":"27","author":"GL Drusano","year":"1985","unstructured":"Drusano GL, Joshi JH, Forrest A, et al (1985) Pharmacokinetics of ceftazidime, alone or in combination with piperacillin or tobramycin, in the sera of cancer patients. Antimicrob Agents Chemother 27:605?607","journal-title":"Antimicrob Agents Chemother"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0021-9258(18)65573-5","volume":"208","author":"GP Elion","year":"1954","unstructured":"Elion GP, Singer S, Hitchings GH (1954) Antagonists of nucleic acid derivatives. Synergism in combinations of biochemically related antimetabolites. J Biol Chem 208:477?488","journal-title":"J Biol Chem"},{"issue":"Suppl B","key":"CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jac\/12.suppl_A.101","volume":"12","author":"V Fainstein","year":"1983","unstructured":"Fainstein V, Bodey GP, Bolivar ER, Keating MJ, McCredie KB, Valdivieso M (1983) A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients. J Antimicrob Chemother 12 [Suppl B]:101?110","journal-title":"J Antimicrob Chemother"},{"key":"CR10","first-page":"1976","volume-title":"Statistical method for rates and proportions","author":"JL Fleiss","year":"1973","unstructured":"Fleiss JL (1973) Statistical method for rates and proportions. Wiley, New York, pp 1976?1978"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1056\/NEJM197809282991304","volume":"299","author":"JA Freiman","year":"1978","unstructured":"Freiman JA, Chalmers TC, Smith H Jr, Kuebler RR (1978) The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 ?negative? trials. N Engl J Med 299:690?694","journal-title":"N Engl J Med"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0002-9343(82)90935-4","volume":"73","author":"CA Jongh de","year":"1982","unstructured":"Jongh CA de, Wade JC, Schimpff SC, Newman KA, Finley RS, Salvatore PC, Moody MR, Standiford HC, Fortner CL, Wiernik PH (1982) Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin. Am J Med 73:89?96","journal-title":"Am J Med"},{"issue":"Suppl 8C","key":"CR13","first-page":"96","volume":"80","author":"CA Jongh de","year":"1986","unstructured":"Jongh CA de, Joshi JH, Newman KA, Moody MR, Wharton R, Standiford HC, Schimpff SC (1986) Antibiotic synergism and response to gram-negative bacteremia in granulocytopenic cancer patients. Am J Med 80 [Suppl 8C]:96?111","journal-title":"Am J Med"},{"issue":"Suppl 5C","key":"CR14","first-page":"101","volume":"80","author":"CA Jongh de","year":"1986","unstructured":"Jongh CA de, Joshi JH, Thompson BW, Newman KA, Finley RS, Moody MR, Salvatore PC, Tenney JH, Drusano GL, Schimpff SC (1986) A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients. Am J Med 80 [Suppl 5C]:101?111","journal-title":"Am J Med"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9343(84)90664-8","volume":"76","author":"JH Joshi","year":"1984","unstructured":"Joshi JH, Schimpff SC, Tenney JH, Newman KA, Jongh CA de (1984) Can antibacterial therapy be discontinued in persistently febrile, granulocytopenic patients? Am J Med 76:450?457","journal-title":"Am J Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00005792-197903000-00004","volume":"58","author":"MJ Keating","year":"1979","unstructured":"Keating MJ, Bodey GP, Valdivieso M, Rodriguez V (1979) A randomized comparative trial of three aminoglycosides ? comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies. Medicine 58:159?170","journal-title":"Medicine"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/infdis\/129.2.187","volume":"129","author":"J Klastersky","year":"1974","unstructured":"Klastersky J, Daneau D, Swings G, Weerts D (1974) Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections. J Infect Dis 129:187?193","journal-title":"J Infect Dis"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0002-9343(77)90669-6","volume":"62","author":"WK Lau","year":"1977","unstructured":"Lau WK, Young LS, Black RE, Winston DJ, Linn\ufffd SR, Weinstein RJ, Hewitt WL (1977) Comparative efficacy and toxicity of amikacin\/carbenicillin versus gentamicin\/carbenicillin in leukopenic patients. A randomized prospecitive trial. Am J Med 62:959?966","journal-title":"Am J Med"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJM198311243092105","volume":"309","author":"PW Lavori","year":"1983","unstructured":"Lavori PW, Louis TA, Bailar JC III, Polansky M (1983) Designs for experiments ? parallel comparisons of treatment. N Engl J Med 309:1291?1299","journal-title":"N Engl J Med"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"S284","DOI":"10.1093\/clinids\/5.Supplement_2.S284","volume":"5","author":"PS Lietman","year":"1983","unstructured":"Lietman PS, Smith CR (1983) Aminoglycoside nephrotoxicity in humans. Rev Infect Dis 5 [Suppl]:S284-S293","journal-title":"Rev Infect Dis"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0002-9343(79)90389-9","volume":"67","author":"LJ Love","year":"1979","unstructured":"Love LJ, Schimpff SC, Hahn DM, Young VM, Standiford HC, Bender JF, Fortner CL, Wiernik PH (1979) Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile, granulocytopenic cancer patients. Am J Med 67:183?193","journal-title":"Am J Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0002-9343(80)90243-0","volume":"68","author":"LJ Love","year":"1980","unstructured":"Love LJ, Schimpff SC, Schiffer CA, Wiernik PH (1980) Improved prognosis for granulocytopenic patients with gram-negative bacteremia. Am J Med 68:643?648","journal-title":"Am J Med"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/AEM.20.1.46-53.1970","volume":"20","author":"JD McLowery","year":"1970","unstructured":"McLowery JD, Jaqua MJ, Selepack ST (1970) Detailed methodology and implementation of a semiautomated serial dilution microtechnique for antimicrobial susceptibility testing. Appl Microbiol 20:46?53","journal-title":"Appl Microbiol"},{"key":"CR24","unstructured":"National Committee for Clinical Laboratory Standards (1983) Tentative standard methods for dilution antimicrobial susceptibility tests for bacteria which grow aerobically. Villanova, Penn"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/AAC.21.1.11","volume":"21","author":"HC Neu","year":"1982","unstructured":"Neu HC, Labthavikul P (1982) Antibacterial activity and ?-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa. Antimicrob Agents Chemother 21:11?18","journal-title":"Antimicrob Agents Chemother"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1128\/AAC.17.5.876","volume":"17","author":"CM O'Callaghan","year":"1980","unstructured":"O'Callaghan CM, Acred P, Harper PB, Ryan DM, Kirby SM, Harding SM (1980) GR 20263, a new broad-spectrum cephalosporin with antipseudomonal activity. Antimicrob Agents Chemother 17:876?883","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl B","key":"CR27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/8.suppl_B.23","volume":"8","author":"I Phillips","year":"1981","unstructured":"Phillips I, Warren C, Shannon K, King A, Hanslo D (1981) Ceftazidime: in vitro antibacterial activity and susceptibility to ?-lactamases compared with that of cefotaxime, moxalactam and other ?-lactam antibiotics. J Antimicrob Chemother 8 [Suppl B]:23?31","journal-title":"J Antimicrob Chemother"},{"key":"CR28","first-page":"1680","volume-title":"Principles and practice of infectious diseases","author":"PA Pizzo","year":"1985","unstructured":"Pizzo PA (1985) Empiric therapy and prevention of infection in the immunocompromised host. In: Mandell GL, Douglas RG Jr, Bennett JE (eds) Principles and practice of infectious diseases, 2nd edn. Wiley, New York, pp 1680?1688","edition":"2nd edn."},{"key":"CR29","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJM198608283150905","volume":"315","author":"P Pizzo","year":"1986","unstructured":"Pizzo P, Hathorn J, Hiemenz J, et al (1986) A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 315:552?558","journal-title":"N Engl J Med"},{"issue":"Suppl B","key":"CR30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/jac\/8.suppl_B.79","volume":"8","author":"HH Schassan","year":"1981","unstructured":"Schassan HH, Fedder J (1981) Activity of ceftazidime and newer antibiotics against gram-negative bacilli. J Antimicrob Chemother 8 [Suppl B]:79?82","journal-title":"J Antimicrob Chemother"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0025-7125(16)31284-6","volume":"61","author":"SC Schimpff","year":"1977","unstructured":"Schimpff SC (1977) Therapy of infection in patients with granulocytopenia. Med Clin North Am 61:1101?1118","journal-title":"Med Clin North Am"},{"key":"CR32","first-page":"5","volume-title":"Clinical approach to infection in the immunocompromised host","author":"SC Schimpff","year":"1981","unstructured":"Schimpff SC, Young VM (1981) Epidemiology and prevention of infection in the immunocompromised host. In: Young CS, Rubin RH (eds) Clinical approach to infection in the immunocompromised host. Plenum Press, New York, pp 5?33"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM197105132841904","volume":"284","author":"SC Schimpff","year":"1971","unstructured":"Schimpff SC, Satterlee W, Young VM, Serpick A (1971) Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 284:1061?1065","journal-title":"N Engl J Med"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0002-9343(84)90662-4","volume":"76","author":"JP Sculier","year":"1984","unstructured":"Sculier JP, Klastersky J (1984) Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia. Am J Med 76:429?435","journal-title":"Am J Med"},{"key":"CR35","volume-title":"Nonparametric statistics for the behavioral sciences","author":"S Siegel","year":"1956","unstructured":"Siegel S (1956) Nonparametric statistics for the behavioral sciences. McGraw-Hill\/Kogakusha, Tokyo"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM198005153022002","volume":"302","author":"CR Smith","year":"1980","unstructured":"Smith CR, Lipsky JJ, Laskin OL, et al (1980) Double blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med 302:1106?1109","journal-title":"N Engl J Med"},{"key":"CR37","first-page":"155","volume":"7","author":"D Waaij van der","year":"1979","unstructured":"Waaij D van der (1979) The colonization resistance of the digestive tract in man and animals. Zentralbl Bakteriol 7 [Suppl]:155?161","journal-title":"Zentralbl Bakteriol"},{"key":"CR38","first-page":"106","volume-title":"Action of antibiotics in patients","author":"D Waaij van der","year":"1981","unstructured":"Waaij D van der (1981) The digestive tract in immunocompromised patients: importance of maintaining its resistance to colonization, especially in hospital inpatients and those taking antibiotics. In: Sabath LD (ed) Action of antibiotics in patients. Huber, Bern Stuttgart Wien, pp 106?118"},{"key":"CR39","series-title":"EORTC monograph series","first-page":"73","volume-title":"Infections in cancer patients","author":"D Waaij van der","year":"1982","unstructured":"Waaij D van der (1982) Gut resistance to colonization: clinical usefulness of selective use of orally administered antimicrobial and antifungal drugs. In: Klastersky J (ed) Infections in cancer patients. (EORTC monograph series) Raven Press, New York, pp 73?85"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S0022172400021653","volume":"69","author":"D Waaij van der","year":"1971","unstructured":"Waaij D van der, Berghuis-de Vries JM, Lekkerkerk JEC, Wess JE van der (1971) Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg 69:405?411","journal-title":"J Hyg"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7326\/0003-4819-97-4-503","volume":"97","author":"JC Wade","year":"1982","unstructured":"Wade JC, Schimpff SC, Newman KA, Wiernik PH (1982) Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med 97:503?508","journal-title":"Ann Intern Med"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0002-9343(84)90100-1","volume":"77","author":"DJ Winston","year":"1984","unstructured":"Winston DJ, Barnes RC, Ho WG, Young LS, Champlin RE, Gale RP (1984) Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patients. Am J Med 77:442?450","journal-title":"Am J Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00366445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00366445\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00366445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,27]],"date-time":"2021-06-27T11:43:20Z","timestamp":1624794200000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00366445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,7]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,7]]}},"alternative-id":["BF00366445"],"URL":"https:\/\/doi.org\/10.1007\/bf00366445","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,7]]}}}